BOSTON--(BUSINESS WIRE)--Etiometry, a pioneering leader in next-generation patient monitoring, has added waveform capabilities to the Etiometry Platform. The company’s T3 Data Aggregation & Visualization software is now able to capture high-resolution waveform data from medical devices deployed throughout the ICU.
Medical researchers can leverage T3 to capture high-frequency biomedical device data to gain further insight into different physiological processes. This data can be fed to the Etiometry Risk Analytics Algorithms for analysis and to the Etiometry Quality Improvement Sandbox for retrieval for retrospective analysis.
According to Etiometry’s CEO Evan Butler, “Hospitals can now capture high-resolution physiological data in a live clinical environment to provide biomedical researchers additional insights into the different processes affecting the recovery of ICU patients. We believe that biomedical device data should not be difficult to obtain, and our waveform capabilities will allow hospitals to easily capture and store high-frequency physiology data such as ECG information.”
Medical researchers using T3 will have access to high-fidelity, high-frequency waveform information that is easy to access and analyze. This new feature is immediately available from Etiometry as an add-on to T3 Data Aggregation & Visualization.
Based in Boston, Etiometry provides next-generation patient monitoring software for hospital ICUs. By consolidating data from many ICU devices, the Etiometry Platform helps clinicians better understand the trajectory of their patients by viewing salient clinical information on a single screen. It fosters more objective communication among care teams and provides a common platform to analyze the best course of treatment for ICU patients. For more information, visit www.etiometry.com.